Sally C. Pipes

340B

Big hospitals are gaming the rural healthcare system, and Congress is helping

Congress has handed hospital giants a new line of taxpayer-funded credit. This summer, Congress included a $50 billion “rural health fund” in the multitrillion-dollar One Big Beautiful Bill Act. The fund’s supporters are touting it as a lifeline for struggling community hospitals. But small-town emergency rooms will not be the ...
Commentary

Yes, Democrats are defending Medicaid for illegal immigrants

“Not a single federal dollar goes to providing health insurance for undocumented immigrants. NOT. ONE. PENNY.” These were the words of Senate Minority Leader Chuck Schumer (D-NY) in a recent X post, after Republicans accused Democrats of shutting down the government in order to keep funding Medicaid for illegal immigrants… ...
Commentary

Republicans shouldn’t cave to Democrats’ shutdown demands

As the government shutdown stretches into its third week, Republicans have signaled some willingness to agree to Democrats’ demand to extend billions of dollars in enhanced premium subsidies for exchange plans beyond their scheduled expiration at the end of this year. That would be a mistake. The enhanced insurance subsidies ...
Commentary

If Health Insurance Premiums Rise Next Year, Blame Democrats

In the ongoing government shutdown saga, Democrats continue to cast themselves as defenders of affordable health insurance… Premiums have been on a steady upward trajectory for more than a decade. Obamacare’s own diktats are why premiums have risen. Read the op-ed here. 
Commentary

How Obamacare Set In Motion Today’s Premium Crisis

Democrats are panicking about a looming 75% average increase in the out-of-pocket cost of insurance premiums next year for the roughly 6% of the population that shops for coverage on Obamacare’s exchanges. Their panic led them to shut down the government at the end of September. The increase is a ...
Commentary

Trump Delivers Mixed Results on Health Reform

Since taking office in January, President Trump has wasted little time advancing health policies he hopes will lower costs, improve quality, and promote innovation. Those are goals worth supporting, to be sure. But the results of his efforts to date have been mixed. Consider Trump’s approach to prescription drug prices. ...
Commentary

Patients Can’t Wait for Federal Action on Knock-Off Medicines

For millions of Americans, the new class of GLP-1 weight-loss drugs are as close to a miracle as modern medicine gets. Sold under brand names like Wegovy and Zepbound, these drugs have proven astoundingly successful at helping patients shed pounds. Unfortunately, a number of unscrupulous companies have sought to capitalize ...
Commentary

Direct-To-Consumer Sales Can Fulfill Trump’s Drug Pricing Promises

The Trump administration wants to enable more Americans to purchase prescription medications directly from manufacturers at transparent, discounted prices—thus collectively saving patients tens of billions of dollars by cutting out middlemen in the drug supply chain. Voters overwhelmingly like the president’s idea. In a recent poll, 90% of Republican voters ...
Commentary

Shut down the enhanced Obamacare subsidies, not the government

Is it worth shutting down the government to keep billions in federal cash flowing to health insurers? That’s a question Republicans should be asking Democrats every chance they get. The minority party has brought business in Washington to a halt as part of a wrongheaded strategy to obscure the out-of-control ...
Commentary

When Drug Firms Stand Up to Price Controls, U.S. Patients Win

Drug maker Bristol Myers Squibb just announced plans to sell its new schizophrenia drug Cobenfy at the same price in both the United Kingdom and the United States. And if the British government refuses, the manufacturer may walk away from the market. The drug maker’s posture portends good news for ...
340B

Big hospitals are gaming the rural healthcare system, and Congress is helping

Congress has handed hospital giants a new line of taxpayer-funded credit. This summer, Congress included a $50 billion “rural health fund” in the multitrillion-dollar One Big Beautiful Bill Act. The fund’s supporters are touting it as a lifeline for struggling community hospitals. But small-town emergency rooms will not be the ...
Commentary

Yes, Democrats are defending Medicaid for illegal immigrants

“Not a single federal dollar goes to providing health insurance for undocumented immigrants. NOT. ONE. PENNY.” These were the words of Senate Minority Leader Chuck Schumer (D-NY) in a recent X post, after Republicans accused Democrats of shutting down the government in order to keep funding Medicaid for illegal immigrants… ...
Commentary

Republicans shouldn’t cave to Democrats’ shutdown demands

As the government shutdown stretches into its third week, Republicans have signaled some willingness to agree to Democrats’ demand to extend billions of dollars in enhanced premium subsidies for exchange plans beyond their scheduled expiration at the end of this year. That would be a mistake. The enhanced insurance subsidies ...
Commentary

If Health Insurance Premiums Rise Next Year, Blame Democrats

In the ongoing government shutdown saga, Democrats continue to cast themselves as defenders of affordable health insurance… Premiums have been on a steady upward trajectory for more than a decade. Obamacare’s own diktats are why premiums have risen. Read the op-ed here. 
Commentary

How Obamacare Set In Motion Today’s Premium Crisis

Democrats are panicking about a looming 75% average increase in the out-of-pocket cost of insurance premiums next year for the roughly 6% of the population that shops for coverage on Obamacare’s exchanges. Their panic led them to shut down the government at the end of September. The increase is a ...
Commentary

Trump Delivers Mixed Results on Health Reform

Since taking office in January, President Trump has wasted little time advancing health policies he hopes will lower costs, improve quality, and promote innovation. Those are goals worth supporting, to be sure. But the results of his efforts to date have been mixed. Consider Trump’s approach to prescription drug prices. ...
Commentary

Patients Can’t Wait for Federal Action on Knock-Off Medicines

For millions of Americans, the new class of GLP-1 weight-loss drugs are as close to a miracle as modern medicine gets. Sold under brand names like Wegovy and Zepbound, these drugs have proven astoundingly successful at helping patients shed pounds. Unfortunately, a number of unscrupulous companies have sought to capitalize ...
Commentary

Direct-To-Consumer Sales Can Fulfill Trump’s Drug Pricing Promises

The Trump administration wants to enable more Americans to purchase prescription medications directly from manufacturers at transparent, discounted prices—thus collectively saving patients tens of billions of dollars by cutting out middlemen in the drug supply chain. Voters overwhelmingly like the president’s idea. In a recent poll, 90% of Republican voters ...
Commentary

Shut down the enhanced Obamacare subsidies, not the government

Is it worth shutting down the government to keep billions in federal cash flowing to health insurers? That’s a question Republicans should be asking Democrats every chance they get. The minority party has brought business in Washington to a halt as part of a wrongheaded strategy to obscure the out-of-control ...
Commentary

When Drug Firms Stand Up to Price Controls, U.S. Patients Win

Drug maker Bristol Myers Squibb just announced plans to sell its new schizophrenia drug Cobenfy at the same price in both the United Kingdom and the United States. And if the British government refuses, the manufacturer may walk away from the market. The drug maker’s posture portends good news for ...
Scroll to Top